MODIFICATION OF COAGULATION IMBALANCE DURING ANTITHROMBIN TREATMENT IN PREECLAMPTIC PATIENTS: OUR EXPERIENCE

Preeclamptic conditions are often associated with a natural inhibitor consumption. Many studies have evidenced validity of antithrombin (AT) treatment during preeclamptic conditions. The aim of the study is to restore a congruous coagulation imbalance with administration of AT under the guide of thromboelastographic monitoring (TEG).